Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/7192
Title: | PATHOPHYSIOLOGICAL SUBSTANTIATION OF THE USE OF A NEW DRUG BASED ON G. LUCIDUM AND ALKHADIA IN THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS COV-2 |
Authors: | Pulat M. Abilov1 , Bakhtiyor U. Iriskulov2 , Zukhra N. Boboeva3 |
Keywords: | coronavirus infection, pathogenesis, acute respiratory syndrome, G. lucidum, Alkhadaya |
Issue Date: | 2022 |
Series/Report no.: | №3; |
Abstract: | The current outbreak of coronavirus disease (COVID-19) is a global emergency as its rapid spread and high mortality rate have caused severe disruption. The number of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is rapidly increasing worldwide. Patients with COVID-19 may develop pneumonia, severe symptoms of acute respiratory distress syndrome (ARDS) and multiple organ failure |
URI: | http://repository.tma.uz/xmlui/handle/1/7192 |
ISSN: | 2186-1326 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
0 Central As J of M 3,22-страницы-1,3,36-44,248-250.pdf | 3.44 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.